whole human genome oligo microarray (one-color (Agilent technologies)
Agilent technologies is a verified supplier 
Agilent technologies manufactures this product 
90
Structured Review
Agilent technologies
whole human genome oligo microarray (one-color
Whole Human Genome Oligo Microarray (One Color, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+human+genome+oligo+microarray+(one-color/pmc04054951-150-2-7
Average 90 stars, based on 1 article reviews
Whole Human Genome Oligo Microarray (One Color, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/whole+human+genome+oligo+microarray+(one-color/pmc04054951-150-2-7
Average 90 stars, based on 1 article reviews
whole human genome oligo microarray (one-color - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: The existence of multipotent stem cells with epithelial-mesenchymal transition features in the human liver bud Article Snippet: Microarray analysis According to Article Title: Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy Article Snippet: A whole Isolation:Article Title: P263 REVERSE CHOLESTEROL TRANSPORT IS NOT INFLUENCED BY HDL COMPOSITION OR THE REDUCED MACROPHAGE ABCG-1 EXPRESSION IN CHRONIC KIDNEY DISEASE RATS Article Snippet: weeks of treatment with both of drugs.. The levels of TC, LDL-C and TG did not differ between groups statistically.. Results: After treatment with atorvastatin level of arachidonate was increased by 41% (from 5.7±0.8% of total fatty acids to 8.4±1.1, p < 0.01). Microarray:Article Title: P263 REVERSE CHOLESTEROL TRANSPORT IS NOT INFLUENCED BY HDL COMPOSITION OR THE REDUCED MACROPHAGE ABCG-1 EXPRESSION IN CHRONIC KIDNEY DISEASE RATS Article Snippet: weeks of treatment with both of drugs.. The levels of TC, LDL-C and TG did not differ between groups statistically.. Results: After treatment with atorvastatin level of arachidonate was increased by 41% (from 5.7±0.8% of total fatty acids to 8.4±1.1, p < 0.01). |